SIGA TECHNOLOGIES/ US8269171067 /

24/05/2024 21:59:58	Chg. +0.01	Volume	Bid-	Ask-	High	Low
7.46USD	+0.13%	10,592 Turnover: 78,551.87	-Bid Size: -	-Ask Size: -	7.53	7.31

GlobeNewswire 07/05 SIGA Reports Financial Results for Three Months Ended March 31, 2024

GlobeNewswire 01/05 SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Fina...

GlobeNewswire 01/04 SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportun...

GlobeNewswire 25/03 SIGA Names Larry Miller General Counsel

GlobeNewswire 22/03 The Brazilian Football Confederation and the International Centre for Sport Security signs at Wemble...

GlobeNewswire 12/03 SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023

GlobeNewswire 12/03 SIGA Declares Special Cash Dividend of $0.60 Per Share

GlobeNewswire 05/03 SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quart...

GlobeNewswire 22/01 SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer

GlobeNewswire 07/11/2023 SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023

GlobeNewswire 26/10/2023 SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quar...

GlobeNewswire 23/10/2023 SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initi...

GlobeNewswire 06/09/2023 SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer

Newsfile Corp 16/06/2022 Sprout AI Announcers se asocia con Active 20-30 Las Cumbres, Rep. de Panamá, su aplicación a los pro...

TeleTrader 27/05/2022 EU to jointly buy antivirals, vaccines against monkeypox

GlobeNewswire 03/03/2022 SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2021

GlobeNewswire 02/03/2022 SIGA Announces Start of TPOXX® Post-Exposure Prophylactic (“PEP”) Clinical Trials

GlobeNewswire 24/02/2022 SIGA Technologies to Host Business Update Call on March 3rd, 2022 Following Release of Fourth Quarte...

GlobeNewswire 02/02/2022 Mesoblast Appoints Dr. Eric Rose as Chief Medical Officer

GlobeNewswire 25/01/2022 SIGA Announces Preclinical Oncology Research Collaboration with Bioarchitech

GlobeNewswire 18/01/2022 SIGA Technologies to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference...

GlobeNewswire 10/01/2022 SIGA Technologies Receives Approval from the European Medicines Agency for Tecovirimat

GlobeNewswire 01/12/2021 SIGA Announces Health Canada Regulatory Approval of Oral TPOXX®

GlobeNewswire 16/11/2021 European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Recommends Approval ...

GlobeNewswire 04/11/2021 SIGA Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2021